跳至主要内容
临床试验/NCT01198314
NCT01198314Unknown2 期

Gradual Withdrawal of Immunosuppression in Long Term Stable Liver Transplant Recipients Using Immunologic Profile Predicting Operational Tolerance

The Catholic University of Korea2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2010年7月最近更新:
适应症

试验速览

阶段
2 期
入组人数
20
试验地点
2
主要终点
number of participants who have the potential for the operational tolerance

研究概览

简要总结

Long-term immunosuppression carries potential adverse effects such as risk of infection, malignancy, renal insufficiency, diabetes and hypertension. In clinical liver transplantation, some liver transplant recipients maintain allograft function without immunosuppressive drugs. This is called as "operational tolerance". Many attempts have been made to identify immunological biomarkers predicting operational tolerant patients. Therefore, the investigators aimed to identify patients who have the potential to be operationally tolerant using biomarkers, withdraw immunosuppressant gradually and stop ultimately with monitoring of biomarkers.

详细描述

Among long term stable liver transplant recipients, we will select some proportion of patients who have the high potential for obtaining operational tolerance using biomarkers.

Then, we will gradually reduce immunosuppressants and monitor biomarkers as well as biochemical tests. The course of tapering off immunosuppressant will take about 1 year.

During withdrawal of immunosuppression, participants will be closely monitored for liver enzyme, immunological profile.

If there are some signs of rejection, liver biopsy will be undertaken and participants will be treated using immunosuppressant.

After complete withdrawal of immunosuppressant, participants will be followed for at least of 1 year.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • long term stable liver transplant recipients

排除标准

  • liver transplant due to autoimmune disease
  • liver transplant due to hepatitis C virus (HCV)
  • history of graft rejection
  • history of biliary infection or stricture

结局指标

主要结局

number of participants who have the potential for the operational tolerance

时间窗: in the 2 years fololowing study enrollment

measure number of patients who can be weaned off immunosuppression completely

次要结局

  • Tolerance biomarker(1 year following immunosuppression withdrawal)
  • immunologic profile related to rejection(up to 2 years following withdrawal of immunosuppression)

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验

Withdrawal of Immunosuppression in Long Term Stable... | 临床试验